Edition:
United Kingdom

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,496.55INR
10:25am GMT
Change (% chg)

Rs6.20 (+0.25%)
Prev Close
Rs2,490.35
Open
Rs2,440.00
Day's High
Rs2,519.00
Day's Low
Rs2,440.00
Volume
692,415
Avg. Vol
642,514
52-wk High
Rs3,177.00
52-wk Low
Rs1,901.15

Chart for

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.11
Market Cap(Mil.): Rs394,104.81
Shares Outstanding(Mil.): 165.88
Dividend: 20.00
Yield (%): 0.84

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Dr.Reddy's Laboratories Launches Melphalan Hydrochloride Injection In U.S.

* SAYS LAUNCH OF MELPHALAN HYDROCHLORIDE FOR INJECTION IN U.S. MARKET Source text - http://bit.ly/2C8souU Further company coverage:

26 Dec 2017

BRIEF-Dr. Reddy's Reaches Settlement With U.S. Government Regarding Compliance With Consumer Product Safety Act

* DR. REDDY'S ANNOUNCES IT HAS REACHED A SETTLEMENT WITH US GOVERNMENT REGARDING COMPANY'S COMPLIANCE WITH CONSUMER PRODUCT SAFETY ACT

19 Dec 2017

BRIEF-Dr.Reddy's Labs Gets EIR From U.S. FDA ‍​For Facility In Hyderabad

* SAYS GETS EIR FROM U.S. FDA ‍​FOR CUSTOM PHARMA SERVICES FACILITY IN HYDERABAD Source text - http://bit.ly/2ANfrXj Further company coverage:

01 Dec 2017

BRIEF-Dr.Reddy's Labs Gets U.S. FDA Nod For Psoriasis Treatment

* SAYS CO, THROUGH UNIT, GETS NDA NOD FOR PSORIASIS TREATMENT Source text: http://bit.ly/2kd95cA Further company coverage:

01 Dec 2017

BRIEF-Dr.Reddy's Laboratories gets German Regulator's Nod For CAPA Plan

* SAYS GERMAN REGULATOR PERMITTED PRODUCTION TO START AGAIN FROM FACILITY FOR EU MARKET‍​

30 Nov 2017

BRIEF-Dr.Reddy's Labs Says U.S. Securities Classs Action Lawsuit Been Served On Co

* SAYS U.S. SECURITIES CLASSS ACTION LAWSUIT BEEN SERVED ON CO BY LAWFIRM REPRESENTING INVESTORS IN CO Source text - http://bit.ly/2zOAdWp Further company coverage:

29 Nov 2017

BRIEF-Dr.Reddy's Laboratories gets EIR from US FDA for Duvvada facility

* Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam‍​

21 Nov 2017

FACTBOX-How corporate numbers on Indian WhatsApp groups compared with actual results

Nov 16 Reuters has documented at least 12 cases of prescient messages about major Indian companies being posted in private WhatsApp groups.

16 Nov 2017

BRIEF-Dr.Reddy's Labs ‍launches clofarabine injection in U.S.

* Says ‍launch of clofarabine injection in U.S. market​ Source text: http://bit.ly/2zBoR7i Further company coverage:

14 Nov 2017

BRIEF-DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET

* DR REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET

02 Nov 2017

Earnings vs. Estimates